当前位置:主页 > 医学论文 > 妇产科论文 >

地屈孕酮和保胎无忧片治疗早期先兆流产的疗效比较

发布时间:2018-06-07 20:48

  本文选题:先兆流产 + 地屈孕酮 ; 参考:《临床检验杂志(电子版)》2016年01期


【摘要】:目的探讨地屈孕酮、保胎无忧片应用于早期先兆流产临床效果。方法选取2014年8月-2015年4月期间我院收治的90例早期先兆流产患者为研究对象,经随机方式分为研究组和对照组,各45例。研究组患者在常规治疗基础上加用保胎无忧片,对照组在常规治疗基础上加用地屈孕酮,记录并比较两组早期先兆流产患者临床疗效及不良反应(胃肠道反应、头痛、皮疹、瘙痒、头晕等)发生情况。结果两组患者保胎成功率的差异无统计学意义(P0.05);两组患者治疗后血清孕酮水平均较之前显著提高,差异有统计学意义(P0.05);研究组患者头痛、皮疹、瘙痒等药物不良反应发生率均显著低于对照组,差异有统计学意义(P0.05)。结论应用保胎无忧片治疗早期先兆流产可获得更为理想疗效及预后,有利于保障患者生活质量及身心健康。
[Abstract]:Objective to investigate the clinical effect of Diflexiprogesterone and Propagation-free tablets in early threatened abortion. Methods from August 2014 to April 2015, 90 patients with early threatened abortion were randomly divided into study group and control group. The patients in the study group were treated with the routine therapy and the patients in the control group were treated with tertroprogesterone on the basis of routine treatment. The clinical efficacy and adverse reactions (gastrointestinal reaction, headache, rash) were recorded and compared between the two groups. Itching, dizziness, etc. Results there was no significant difference in the success rate of fetal preservation between the two groups (P 0.05), the serum progesterone levels in both groups were significantly higher than those before treatment, and the difference was statistically significant (P 0.05). The incidence of adverse drug reactions such as pruritus was significantly lower than that of the control group (P 0.05). Conclusion the treatment of early threatened abortion with Baofei worry-free tablet can obtain more ideal curative effect and prognosis, and is beneficial to the protection of patients' quality of life and physical and mental health.
【作者单位】: 上海新华医院崇明分院妇产科;
【分类号】:R714.21

【相似文献】

相关期刊论文 前3条

1 朱立新;;地屈孕酮和保胎无忧片治疗早期先兆流产的疗效对比观察[J];中国临床新医学;2013年01期

2 朱立新;;地屈孕酮及保胎无忧片治疗早期先兆流产的疗效分析[J];临床医学;2013年01期

3 ;[J];;年期



本文编号:1992751

资料下载
论文发表

本文链接:https://www.wllwen.com/yixuelunwen/fuchankeerkelunwen/1992751.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户89cfb***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com